Express Scripts Holding Co (ESRX) Position Trimmed by IBM Retirement Fund

IBM Retirement Fund reduced its position in Express Scripts Holding Co (NASDAQ:ESRX) by 11.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,499 shares of the company’s stock after selling 1,606 shares during the quarter. IBM Retirement Fund’s holdings in Express Scripts were worth $863,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. SeaCrest Wealth Management LLC purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $105,000. Aevitas Wealth Management Inc. purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $128,000. Financial Gravity Companies Inc. purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $142,000. ClariVest Asset Management LLC increased its position in shares of Express Scripts by 31,700.0% during the first quarter. ClariVest Asset Management LLC now owns 2,226 shares of the company’s stock worth $153,000 after acquiring an additional 2,219 shares during the period. Finally, Virtue Capital Management LLC purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $176,000. 85.82% of the stock is currently owned by institutional investors.

In other Express Scripts news, VP Everett Neville sold 4,895 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christine Houston sold 19,889 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

Shares of ESRX opened at $77.08 on Monday. The company has a market capitalization of $43.30 billion, a price-to-earnings ratio of 10.86, a PEG ratio of 0.97 and a beta of 0.98. Express Scripts Holding Co has a twelve month low of $55.80 and a twelve month high of $85.07. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.69 and a quick ratio of 0.56.

Express Scripts (NASDAQ:ESRX) last announced its earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.76 by $0.01. The company had revenue of $24.77 billion during the quarter, compared to the consensus estimate of $24.80 billion. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. Express Scripts’s revenue was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.33 earnings per share. equities analysts predict that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on the stock. BidaskClub lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday, February 14th. Jefferies Group lowered shares of Express Scripts from a “buy” rating to a “hold” rating and set a $91.00 price objective on the stock. in a report on Thursday, March 8th. Maxim Group lifted their price objective on shares of Express Scripts from $87.00 to $101.00 in a report on Wednesday, February 28th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a report on Monday, March 12th. Finally, Zacks Investment Research lowered shares of Express Scripts from a “hold” rating to a “sell” rating in a report on Tuesday, May 1st. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the company’s stock. Express Scripts currently has a consensus rating of “Hold” and an average target price of $82.50.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply